Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Bucher

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Chemical Theory and Computation|August 21, 2012
Exploring the Photophysical Properties of Molecular Systems Using Excited State Accelerated ab Initio Molecular DynamicsJuan Manuel Ortiz-Sánchez, Denis Bucher, Levi C T Pierce, et al.
PNAS Nexus|February 6, 2023
Apo and ligand-bound high resolution Cryo-EM structures of the human Kv3.1 channel reveal a novel binding site for positive modulatorsMathieu Botte, Sophie Huber, Denis Bucher, et al.
Journal of the American Chemical Society|December 22, 2012
Fluoroketone inhibition of Ca(2+)-independent phospholipase A2 through binding pocket association defined by hydrogen/deuterium exchange and molecular dynamicsYuan-Hao Hsu, Denis Bucher, Jian Cao, et al.
Communications Chemistry|May 13, 2026
An integrated experimental and computational pipeline for crystallographic fragment screening of membrane protein in the lipid cubic phaseChia-Ying Huang, Robert Cheng, Alexander Metz, et al.
Communications Chemistry|June 1, 2023
Crystal structure of adenosine A<sub>2A</sub> receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interactionTobias Claff, Jonathan G Schlegel, Jan H Voss, et al.
Journal of Medicinal Chemistry|December 26, 2023
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312Taouès Temal-Laib, Christophe Peixoto, Nicolas Desroy, et al.
Journal of Medicinal Chemistry|March 29, 2024
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory DiseasesChristophe Peixoto, Agnes Joncour, Taouès Temal-Laib, et al.
Journal of Medicinal Chemistry|September 28, 2021
Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic DiseasesOscar Mammoliti, Koen Jansen, Sandy El Bkassiny, et al.
Journal of Medicinal Chemistry|July 25, 2025
Structure-Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 InhibitorHans Kelgtermans, Maxim De Wachter, Stijn Heyndrickx, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Chemical Theory and Computation|August 21, 2012
Exploring the Photophysical Properties of Molecular Systems Using Excited State Accelerated ab Initio Molecular DynamicsJuan Manuel Ortiz-Sánchez, Denis Bucher, Levi C T Pierce, et al.
PNAS Nexus|February 6, 2023
Apo and ligand-bound high resolution Cryo-EM structures of the human Kv3.1 channel reveal a novel binding site for positive modulatorsMathieu Botte, Sophie Huber, Denis Bucher, et al.
Journal of the American Chemical Society|December 22, 2012
Fluoroketone inhibition of Ca(2+)-independent phospholipase A2 through binding pocket association defined by hydrogen/deuterium exchange and molecular dynamicsYuan-Hao Hsu, Denis Bucher, Jian Cao, et al.
Communications Chemistry|May 13, 2026
An integrated experimental and computational pipeline for crystallographic fragment screening of membrane protein in the lipid cubic phaseChia-Ying Huang, Robert Cheng, Alexander Metz, et al.
Communications Chemistry|June 1, 2023
Crystal structure of adenosine A<sub>2A</sub> receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interactionTobias Claff, Jonathan G Schlegel, Jan H Voss, et al.
Journal of Medicinal Chemistry|December 26, 2023
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312Taouès Temal-Laib, Christophe Peixoto, Nicolas Desroy, et al.
Journal of Medicinal Chemistry|March 29, 2024
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory DiseasesChristophe Peixoto, Agnes Joncour, Taouès Temal-Laib, et al.
Journal of Medicinal Chemistry|September 28, 2021
Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic DiseasesOscar Mammoliti, Koen Jansen, Sandy El Bkassiny, et al.
Journal of Medicinal Chemistry|July 25, 2025
Structure-Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 InhibitorHans Kelgtermans, Maxim De Wachter, Stijn Heyndrickx, et al.
Pageof 3